Bertamini, L., Fokkema, C., Rodriguez-Otero, P., Duin, M. V., Terpos, E., D’Agostino, M., Velden, V. H. J. V. D., Donk, N. W. C. J. V. D., Delforge, M., Driessen, C., Hajek, R., Einsele, H., Vangsted, A., Vieyra, D., Attar, R., Sitthi-Amorn, A., Carson, R., Schjesvold, F., Robak, P., Beksac, M., Spencer, A., Broijl, A., Cupedo, T., Moreau, P., Boccadoro, M., Sonneveld, P. (2026). Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone. Blood. https://doi.org/10.1182/blood.2025030113